Latest News and Press Releases
Want to stay updated on the latest news?
-
Reports 13.4% Increase in AUM and 0.9% Increase in NAV Year-Over-Year Annual ROE of 9.1% Beats Previous Year ROE of 7.5% and the BDC Industry Average of 4.3% Net Deployments of $101.1 Million for...
-
FRISCO, TX, May 05, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE; NYSE Texas: CRK) today reported financial and operating results for the quarter ended...
-
Quarter End AUM of $35.1 Billion (+12.5% versus Q1 2025)Quarterly Revenues Grew 14.9% to $65.9 MillionFirst Quarter EPS of $0.66 versus $0.81 in the First Quarter of 2025Strong Liquidity Position and...
-
Closed Plus Disposition Pipeline Totaling $132 Million, of Which 68% Are Office Sales, Further Advancing Strategic Reduction in Office Exposure Reduced Net Debt by $1.3 Billion Year-Over-Year;...
-
Over 3 million Paid Subscribers, up 3% over Q1 2025 Q1 2026 revenue of $159.5 million, down 2% compared to Q1 2025 Net income of $20.3 million, down 15% compared to Q1 2025 Recurring semi-annual...
-
Astera Labs Reports First Quarter 2026 Financial Results
-
ATHENS, Greece, May 05, 2026 (GLOBE NEWSWIRE) -- TEN Ltd. (NYSE: TEN) (“TEN” or the “Company”), a leading diversified crude, product and LNG tanker operator, today announced that its Board of...
-
Year-Over-Year Sales Growth Achieved Across All Three Product Lines; Positive Sales Trends Continued in April Sand State Strategy on Track with Double-Digit Sales Growth in Florida Gross Margin...
-
First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE...
-
New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The hemophilia clinical...